Clinical trials
Phase 2 Neoplasms, Germ Cell and Embryonal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 11 |
| Recruiting | 6 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute, Slovakia | 5 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3 |
| Indiana University | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Nabil Adra | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Barts & The London NHS Trust | 1 |
| BioNTech SE | 1 |
| Blokhin's Russian Cancer Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms, Germ Cell and Embryonal | 53 |
| Testicular Neoplasms | 15 |
| Brain Neoplasms | 7 |
| Neoplasms | 7 |
| Sarcoma | 5 |
| Carcinoma | 4 |
| Medulloblastoma | 4 |
| Recurrence | 4 |
| Astrocytoma | 3 |
| Central Nervous System Neoplasms | 3 |
Trials
Showing 51 to 53 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.